Page 1

Interim Report 1 ( 2021-05-01 - 2021-07-31 ) Phase Holographic Imaging PHI AB ( publ ) Lund , September 29 , 2021 MAY 2021 - JULY 2021 Net sales 2 373 ( 131 ) KSEK Operating result before depreciation ( EBITDA ) -3 439 ( -4 549 ) KSEK Net result -4 469 ( -6 417 ) KSEK Earnings per share Gross margin -0.31 ( -0.45 ) SEK 60 ( -20 ) % IN SHORT • Sales in May - July surpassed sales during any previous quarter . Based on the increasing number of customer inquiries , sales are expected to continue to grow . The company's distribution network has been expanded and reworked into a leaner and more cost - effective partner network , which is anticipated to increase revenues and reduce costs per unit sold . • In August , the company entered a partnership with the US - based RegenMed Development Organization to establish PHI's HoloMonitor technology as a standard tool for quality assurance in large - scale manufacturing of artificial organs . • The second validation phase of the HoloMonitor fluorescence module has only revealed some minor issues that are not expected to delay the market launch of the fluorescence module notably .